Buren Amman
Analyst
Piper Sandler
Equibles does not estimate personal net worth.
About Buren Amman
Buren Amman is recorded as Analyst at Piper Sandler. Buren Amman has spoken on 1 earnings call across 1 company, most recently for Kymera Therapeutics, Inc. on February 26, 2026. The companies whose calls Buren Amman spoke on are classified in the Healthcare sector.
Buren Amman on recent calls
“For the face-to-be AD trial, what measures are you taking in the trial to mitigate against placebo response? For example, will you be requiring photographic evidence of AD at baseline, you know, to provide evidence of moderate to severe disease on screening?”
Affiliation history
-
Piper Sandler
Analyst
Transcript header (unverified)
Current